Cayman Chemical and Curapath Collaborate to Expand Access to PEG-Free Shielding Lipids#USA#Ann_Arbor#lipid_nanoparticles#Cayman_Chemical#Curapath
Cayman Chemical and Curapath Collaborate to Expand Access to PEG-Free Shielding Lipids
Cayman Chemical and Curapath join forces to enhance the availability of PEG-free shielding lipids aimed at innovative drug delivery systems and therapies.
third-news.com
September 3, 2025 at 6:27 PM
Cayman Chemical and Curapath Collaborate to Expand Access to PEG-Free Shielding Lipids#USA#Ann_Arbor#lipid_nanoparticles#Cayman_Chemical#Curapath
Evonik Enhances Lipid-Based Drug Delivery with New GMP Facility in Vancouver#Canada#Vancouver#Evonik#lipid_nanoparticles#GMP_Facility
Evonik Enhances Lipid-Based Drug Delivery with New GMP Facility in Vancouver
Evonik is making a significant investment in a new GMP facility in Vancouver to enhance lipid-based drug delivery, addressing the growing demand for advanced pharmaceuticals.
third-news.com
August 28, 2026 at 7:08 AM
Evonik Enhances Lipid-Based Drug Delivery with New GMP Facility in Vancouver#Canada#Vancouver#Evonik#lipid_nanoparticles#GMP_Facility
Galmed Develops Innovative LNP Formulation of Aramchol Targeting Heart Diseases#Israel#lipid_nanoparticles#Galmed_Pharmaceuticals#Aramchol#Ramat-Gan
Galmed Develops Innovative LNP Formulation of Aramchol Targeting Heart Diseases
Galmed Pharmaceuticals has partnered with Barcode Nanotech to create a groundbreaking LNP formulation of Aramchol, targeting heart diseases and improving treatment options.
third-news.com
July 16, 2026 at 11:44 AM
Galmed Develops Innovative LNP Formulation of Aramchol Targeting Heart Diseases#Israel#lipid_nanoparticles#Galmed_Pharmaceuticals#Aramchol#Ramat-Gan
Understanding the Future of Targeted Lipid Nanoparticle Development in Preclinical Research#Canada#Toronto#lipid_nanoparticles#Preclinical_Research#Xtalks
Understanding the Future of Targeted Lipid Nanoparticle Development in Preclinical Research
Join Xtalks' upcoming webinar to explore advanced lipid nanoparticles (LNPs) targeting strategies and their implications for preclinical work in drug development.
third-news.com
July 13, 2026 at 12:36 PM
Understanding the Future of Targeted Lipid Nanoparticle Development in Preclinical Research#Canada#Toronto#lipid_nanoparticles#Preclinical_Research#Xtalks
Join Phosphorex and Partners for a Deep Dive into Lipid Nanoparticle Development#USA#lipid_nanoparticles#Hopkinton#Phosphorex#NOF_Corporation
Join Phosphorex and Partners for a Deep Dive into Lipid Nanoparticle Development
Phosphorex is teaming up with notable partners for a virtual panel aimed at enhancing targeted lipid nanoparticle development. Don't miss this opportunity for insightful discussions!
third-news.com
June 24, 2026 at 12:18 PM
Join Phosphorex and Partners for a Deep Dive into Lipid Nanoparticle Development#USA#lipid_nanoparticles#Hopkinton#Phosphorex#NOF_Corporation
Lipid Nanoparticles Market Expected to Surge to $3.1 Billion by 2033#None#lipid_nanoparticles#Drug_Delivery#mRNA_vaccines
Lipid Nanoparticles Market Expected to Surge to $3.1 Billion by 2033
The lipid nanoparticles market is projected to reach $3.1 billion by 2033, driven by demand for advanced drug delivery methods and mRNA therapies.
third-news.com
March 5, 2026 at 4:07 PM
Lipid Nanoparticles Market Expected to Surge to $3.1 Billion by 2033#None#lipid_nanoparticles#Drug_Delivery#mRNA_vaccines
Mana.bio Introduces Mina™, The First AI Agent for Lipid Nanoparticles Based on Large Language Models#USA#Boston#Mana.bio#lipid_nanoparticles#Mina™
Mana.bio Introduces Mina™, The First AI Agent for Lipid Nanoparticles Based on Large Language Models
Mana.bio has launched Mina™, the world's first AI agent tailored for lipid nanoparticles, marking a significant advance in RNA delivery and therapeutic development.
third-news.com
September 17, 2025 at 4:41 PM
Mana.bio Introduces Mina™, The First AI Agent for Lipid Nanoparticles Based on Large Language Models#USA#Boston#Mana.bio#lipid_nanoparticles#Mina™
Revolutionizing RNA Delivery: Introducing Mina™, the All-New AI Agent for Lipid Nanoparticles#USA#Boston#Mana.bio#lipid_nanoparticles#Mina
Revolutionizing RNA Delivery: Introducing Mina™, the All-New AI Agent for Lipid Nanoparticles
Mana.bio has launched Mina™, the first AI agent designed specifically for lipid nanoparticles, enhancing RNA delivery. This tool promises to advance scientific research and gene therapy.
third-news.com
September 17, 2025 at 1:31 PM
Revolutionizing RNA Delivery: Introducing Mina™, the All-New AI Agent for Lipid Nanoparticles#USA#Boston#Mana.bio#lipid_nanoparticles#Mina
Genprex Advances Diabetes Gene Therapy Using Innovative Non-Viral Methods at 2025 ADA Sessions#USA#Chicago#lipid_nanoparticles#Genprex#diabetes
Genprex Advances Diabetes Gene Therapy Using Innovative Non-Viral Methods at 2025 ADA Sessions
Genprex has presented groundbreaking research at the 2025 American Diabetes Association sessions, showcasing a novel non-viral delivery system for diabetes gene therapy.
third-news.com
June 23, 2025 at 1:35 PM
Genprex Advances Diabetes Gene Therapy Using Innovative Non-Viral Methods at 2025 ADA Sessions#USA#Chicago#lipid_nanoparticles#Genprex#diabetes
LNP Alliance: A New Era in Lipid Nanoparticle Drug Development Collaboration#USA#Drug_Development#lipid_nanoparticles#LNP_Alliance#Hopkinton
LNP Alliance: A New Era in Lipid Nanoparticle Drug Development Collaboration
The formation of the LNP Alliance, featuring Phosphorex, NOF Corporation, and others, aims to revolutionize lipid nanoparticle technology and drug development.
third-news.com
May 8, 2025 at 2:02 PM
LNP Alliance: A New Era in Lipid Nanoparticle Drug Development Collaboration#USA#Drug_Development#lipid_nanoparticles#LNP_Alliance#Hopkinton
Exploring the Fundamental and Applied Aspects of LNP for RNA Drug Development#Japan#Tokyo#lipid_nanoparticles#RNA_Drugs#CMC_Research
Exploring the Fundamental and Applied Aspects of LNP for RNA Drug Development
Join the upcoming seminar hosted by CMC Research focusing on the principles and applications of lipid nanoparticles in RNA drug development. Learn from experts.
third-news.com
April 11, 2025 at 12:33 AM
Exploring the Fundamental and Applied Aspects of LNP for RNA Drug Development#Japan#Tokyo#lipid_nanoparticles#RNA_Drugs#CMC_Research
Mana.bio Unveils Advanced AI Model Enhancing RNA Delivery via Lipid Nanoparticles#Israel#AI_Technology#Tel_Aviv#Mana.bio#lipid_nanoparticles
Mana.bio Unveils Advanced AI Model Enhancing RNA Delivery via Lipid Nanoparticles
Mana.bio has made significant strides in RNA delivery systems, showcasing AI-driven lipid nanoparticles that enhance tolerability and efficacy, promising a transformative impact on therapeutic developments.
third-news.com
December 11, 2024 at 1:21 PM
Mana.bio Unveils Advanced AI Model Enhancing RNA Delivery via Lipid Nanoparticles#Israel#AI_Technology#Tel_Aviv#Mana.bio#lipid_nanoparticles